A 65-year-old man with COPD (FEV1 45% predicted, frequent exacerbations) is on short-acting bronchodilators only. According to Canadian Thoracic Socie...

Question

A 65-year-old man with COPD (FEV1 45% predicted, frequent exacerbations) is on short-acting bronchodilators only. According to Canadian Thoracic Society COPD pharmacotherapy guidance, which change is most appropriate?

Accepted Answer

Initiate long-acting muscarinic antagonist (LAMA) plus long-acting beta-agonist (LABA) and consider inhaled corticosteroid addition if exacerbations persist

Answer

Continue short-acting bronchodilators only

Answer

Start inhaled corticosteroid monotherapy

Answer

Use oral theophylline as first-line controller

Answer

Rely solely on systemic steroids during exacerbations

ca-mccqe1 MCQ (SBA): COPD pharmacologic management

A 65-year-old man with COPD (FEV1 45% predicted, frequent exacerbations) is on short-acting bronchodilators only. According to Canadian Thoracic Society COPD pharmacotherapy guidance, which change is most appropriate?